Apollo Hospitals Ltd. posted a 42% rise in its net profit in the first quarter of this financial year, beating analysts' expectations.
The company has posted a consolidated bottom-line of Rs 433 crore in quarter ended June. This is in comparison to a profit of Rs 305 crore in the same quarter of the previous fiscal year, according to its stock exchange notification on Tuesday.
Analysts tracked by Bloomberg expected the hospital chain to remain profitable, as they had a consensus estimate of Rs 377.2 crore.
Revenue increased by 14.9% year-on-year for the three months ended June, reaching Rs 5,842 crore. Operating income, or earnings before interest, taxes, depreciation, and amortisation, rose 26.2% year-on-year to Rs 852 crore. The Ebitda margin expanded to 14.6%.
Apollo Hospitals Q1 FY26 Highlights (Consolidated, YoY)
Revenue up 14.9% to Rs 5,842.1 crore versus Rs 5,085.6 crore (Estimate: Rs 5,771.4 crore).
Net profit up 42% to Rs 432.8 crore versus Rs 305.2 crore (Estimate: Rs 377.20 crore).
Ebitda up 26% to Rs 851.9 crore versus Rs 675.1 crore (Estimate: Rs 800.40 crore).
Margin at 14.6% versus 13.3% (Estimate: 13.87%).
The quarterly earnings were shared after the market hours. The stock settled 0.08% lower at Rs 7,253 apiece on the NSE, compared to a 0.46% decline in the benchmark Nifty 50.
Apollo Hospital's shares have risen 11.29% in the last 12 months and fallen 0.82% year-to-date.
Out of 31 analysts tracking the company, 28 maintain a 'buy' rating, two recommend a 'hold' and one suggests 'sell', according to Bloomberg data. The average 12-month consensus price target of Rs 8,093.93 implies a potential upside of 11.8%.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
